Neuro-Oncology Reviews

Volume 25 Number 13
15 July 2023

Home > Publications > Neuro-Oncology Reviews > Volume 25, Year 2023 > Number 13, 15 July

Czarnywojtek A, Gut P, Borowska M, Dyrka K, Ruchała M, Ferlito A.
A new hypothesis in the treatment of recurrent glioblastoma multiforme (GBM). Part 1: Introduction.
Pol Merkur Lekarski. 2023
Jul;51(4):430-432. doi: 10.36740/Merkur202304119. PMID: 37756465. Perspective. ˍ


Eckerdt F, Platanias LC.
Emerging Role of Glioma Stem Cells in Mechanisms of Therapy Resistance.
Cancers (Basel). 2023 Jul 1;15(13):3458. doi: 10.3390/cancers15133458. PMID: 37444568. Review. ˍ

Damodharan S, Abbott A, Kellar K, Zhao Q, Dey M.
Molecular Characterization and Treatment Approaches for Pediatric H3 K27-Altered Diffuse Midline Glioma: Integrated Systematic Review of Individual Clinical Trial Participant Data.
Cancers (Basel). 2023 Jul 3;15(13):3478. doi: 10.3390/cancers15133478. PMID: 37444588. Review. ˍ

Halatsch ME.
Special Issue: Principal Challenges in the Adjuvant Treatment of Glioblastoma.
Biomedicines. 2023 Jul 3;11(7):1881. doi: 10.3390/biomedicines11071881. PMID: 37509520. Editorial. ˍ

Kringel R, Lamszus K, Mohme M.
Chimeric Antigen Receptor T Cells in Glioblastoma-Current Concepts and Promising Future.
Cells. 2023 Jul 3;12(13):1770. doi: 10.3390/cells12131770. PMID: 37443804. Review. ˍ

Leskinen S, Shah HA, Yaffe B, Schneider SJ, Ben-Shalom N, Boockvar JA, D'Amico RS, Wernicke AG.
Hippocampal avoidance in whole brain radiotherapy and prophylactic cranial irradiation: a systematic review and meta-analysis.
J Neurooncol. 2023 Jul 3. doi: 10.1007/s11060-023-04384-6. PMID: 37395975. Review, Meta-analysis˰ ˍ

Li Y, Fang B.
Neural stem cell-derived extracellular vesicles: The light of central nervous system diseases.
Biomed Pharmacother. 2023 Jul 3;165:115092. doi: 10.1016/j.biopha.2023.115092. PMID: 37406512. Review. ˍ

Yang Y, Cheng N, Luo Q, Shao N, Ma X, Chen J, Luo L, Xiao Z.
How Nanotherapeutic Platforms Play a Key Role in Glioma? A Comprehensive Review of Literature.
Int J Nanomedicine. 2023 Jul 3;18:3663-3694. doi: 10.2147/IJN.S414736. PMID: 37427368. Review. ˍ


Cho NS, Wong WK, Nghiemphu PL, Cloughesy TF, Ellingson BM.
The Future Glioblastoma Clinical Trials Landscape: Early Phase 0, Window of Opportunity, and Adaptive Phase I-III Studies.
Curr Oncol Rep. 2023 Jul 4. doi: 10.1007/s11912-023-01433-1. PMID: 37402043. Review. ˍ

Wu Y, Qian Y, Peng W, Qi X.
Functionalized nanoparticles crossing the brain-blood barrier to target glioma cells.
PeerJ. 2023 Jul 4;11:e15571. doi: 10.7717/peerj.15571. PMID: 37426416. Review. ˍ

Yang J, He Z, Li M, Hong T, Ouyang T.
Risk of intracranial hemorrhage with direct oral anticoagulation versus low molecular weight heparin in the treatment of brain tumor-associated venous thromboembolism: A meta-analysis.
J Stroke Cerebrovasc Dis. 2023 Jul 4;32(8):107243. doi: 10.1016/j.jstrokecerebrovasdis.2023.107243. PMID: 37413715. Meta-analysis˰ ˍ

Rodriguez SMB, Kamel A, Ciubotaru GV, Onose G, Sevastre AS, Sfredel V, Danoiu S, Dricu A, Tataranu LG.
An Overview of EGFR Mechanisms and Their Implications in Targeted Therapies for Glioblastoma.
Int J Mol Sci. 2023 Jul 5;24(13):11110. doi: 10.3390/ijms241311110. PMID: 37446288. Review. ˍ

Guo B, Zhang S, Xu L, Sun J, Chan WL, Zheng P, Zhang J, Zhang L.
Efficacy and safety of innate and adaptive immunotherapy combined with standard of care in high-grade gliomas: a systematic review and meta-analysis.
Front Immunol. 2023 Jul 6;14:966696. doi: 10.3389/fimmu.2023.966696. PMID: 37483593. Review, Meta-analysis. ˍ

Louis DN.
A vade mecum for crossing the second translational "valley of death" in brain tumor classification.
Brain Pathol. 2023 Jul 6:e13183. doi: 10.1111/bpa.13183. PMID: 37409518. Perspective. ˍ

Mukherjee T, Pournik O, Lim Choi Keung SN, Arvanitis TN.
Clinical Decision Support Systems for Brain Tumour Diagnosis and Prognosis: A Systematic Review.
Cancers (Basel). 2023 Jul 6;15(13):3523. doi: 10.3390/cancers15133523. PMID: 37444633. Review. ˍ

Woods RR, Lesser GJ.
Management of Thromboembolic Disease in Patients with Primary and Metastatic Brain Tumors.
Curr Treat Options Oncol. 2023 Jul 6. doi: 10.1007/s11864-023-01116-w. PMID: 37407888. Review. ˍ

Bernstock JD, Blitz SE, Hoffman SE, Gerstl JVE, Chiocca EA, Friedman GK.
Recent oncolytic virotherapy clinical trials outline a roadmap for the treatment of high-grade glioma.
Neurooncol Adv. 2023 Jul 7;5(1):vdad081. doi: 10.1093/noajnl/vdad081. PMID: 37497017. Review. ˍ


Sabahi M, Salehipour A, Bazl MSY, Rezaei N, Mansouri A, Borghei-Razavi H.
Local immunotherapy of glioblastoma: A comprehensive review of the concept.
J Neuroimmunol. 2023 Jul 7;381:578146. doi: 10.1016/j.jneuroim.2023.578146. PMID: 37451079. Review˰ ˍ

Hu X, Jiang C, Gao Y, Xue X.
Human dendritic cell subsets in the glioblastoma-associated microenvironment.
J Neuroimmunol. 2023 Jul 10;383:578147
. doi: 10.1016/j.jneuroim.2023.578147. PMID: 37643497. Review˰ ˍ

Bai H, Jiang C.
Editorial: Advances in surgical approaches for the treatment of glioma.
Front Oncol. 2023 Jul 11;13:1236341. doi: 10.3389/fonc.2023.1236341. PMID: 37496655. Editorial. ˍ

Cedergren Weber G, Timpka J, Rydelius A, Bengzon J, Odin P.
Tumoral parkinsonism-Parkinsonism secondary to brain tumors, paraneoplastic syndromes, intracranial malformations, or oncological intervention, and the effect of dopaminergic treatment.
Brain Behav. 2023 Jul 11:e3151. doi: 10.1002/brb3.3151. PMID: 37433071. Review. ˍ

Erkan B, Demir S, Akpinar E, Akkurt TS, Tanriverdi O, Gunaldi O.
A rare tumor in the sellar region: ganglioglioma, a case report and a general overview.
Childs Nerv Syst. 2023 Jul 11. doi: 10.1007/s00381-023-06073-1. PMID: 37432397. Case report, Review˰ ˍ

Nowak I, Madej M, Secemska J, Sarna R, Strzalka-Mrozik B.
Virus-Based Biological Systems as Next-Generation Carriers for the Therapy of Central Nervous System Diseases.
Pharmaceutics. 2023 Jul 11;15(7):1931. doi: 10.3390/pharmaceutics15071931. PMID: 37514117. Review. ˍ

Guldager R, Nordentoft S, Poulsen I, Aadal L, Loft MI.
Wants and needs for involvement reported by relatives of patients with a malignant brain tumour: a scoping review.
JBI Evid Synth. 2023 Jul 12. doi: 10.11124/JBIES-22-00311. PMID: 37435678. Review˰ ˍ

Langen KJ, Galldiks N, Mauler J, Kocher M, Filß CP, Stoffels G, Régio Brambilla C, Stegmayr C, Willuweit A, Worthoff WA, Shah NJ, Lerche C, Mottaghy FM, Lohmann P.
Hybrid PET/MRI in Cerebral Glioma: Current Status and Perspectives.
Cancers (Basel). 2023 Jul 12;15(14):3577. doi: 10.3390/cancers15143577. PMID: 37509252. Review. ˍ

Wu O, Clift GW, Hilliard S, Ip M.
Evaluating the use of intraoperative magnetic resonance imaging in paediatric brain tumour resection surgeries: a literature review.
J Med Radiat Sci. 2023 Jul 12. doi: 10.1002/jmrs.707. PMID: 37434551. Review. ˍ

Aziz PA, Memon SF, Hussain M, Memon AR, Abbas K, Qazi SU, Memon RAR, Qambrani KA, Taj O, Ghazanfar S, Ellahi A, Ahmed M.
Supratotal Resection - An Emerging Concept Of Gliomablastoma Multiforme Surgery - Systematic Review And Meta-Analysis.
World Neurosurg. 2023 Jul 13:S1878-8750(23)00950-6. doi: 10.1016/j.wneu.2023.07.020. PMID: 37451363. Review, Meta-analysis˰ ˍ

Gupta T, Selvarajan JMP, Kannan S, Menon N, Dasgupta A, Chatterjee A.
Updated systematic review and meta-analysis of extended adjuvant temozolomide in patients with newly diagnosed glioblastoma.
Neurooncol Adv. 2023 Jul 13;5(1):vdad086
. doi: 10.1093/noajnl/vdad086. PMID: 37638346. Review. ˍ

McDougall E, Breen LJ, Nowak AK, Dhillon HM, Halkett GKB.
Psychosocial interventions for personality and behavior changes in adults with a brain tumor: A scoping review.
Neurooncol Pract. 2023 Jun 13;10(5):408-417
. doi: 10.1093/nop/npad031. PMID: 37720389. Review˰ ˍ

Zhang L, Dimberg A, Rasouli J.
Editorial: The blood-brain barrier in brain tumors: molecular mechanisms and therapeutic strategies.
Front Neurol. 2023 Jul 13;14:1225594. doi: 10.3389/fneur.2023.1225594. PMID: 37521282. Editorial. ˍ

Hsu TI.
Editorial: Metabolic reprogramming for acquiring therapeutic resistance in glioblastoma.
Front Oncol. 2023 Jul 14;13:1220063. doi: 10.3389/fonc.2023.1220063. PMID: 37519794. Editorial. ˍ

Jia H, Zhang H, Miao F, Lu D, Wang X, Gong L, Fan Y.
CSF Biopsy in Glioma: A Brief Review.
Methods Mol Biol. 2023 Jul 15;2695:121-126. doi: 10.1007/978-1-0716-3346-5_8. PMID: 37450115. Review˰ ˍ

Krajcer A, Grzywna E, Lewandowska-Łańcucka J.
Strategies increasing the effectiveness of temozolomide at various levels of anti-GBL therapy.
Biomed Pharmacother. 2023 Jul 15;165:115174. doi: 10.1016/j.biopha.2023.115174. PMID: 37459661. Review. ˍ

Mehta NH, Shah HA, D'Amico RS.
Sonodynamic Therapy and Sonosensitizers for Glioma Treatment: A Systematic Qualitative Review.
World Neurosurg. 2023 Jul 15:S1878-8750(23)00961-0. doi: 10.1016/j.wneu.2023.07.030. PMID: 37454909. Review˰ ˍ

Nguyen AV, Soto JM, Gonzalez SM, Murillo J, Trumble ER, Shan FY, Huang JH.
H3G34-Mutant Gliomas-A Review of Molecular Pathogenesis and Therapeutic Options.
Biomedicines. 2023 Jul 15;11(7):2002. doi: 10.3390/biomedicines11072002. PMID: 37509641. Review. ˍ